Navigation Links
Quorum Review’s J. Claire Carbary Presents at PRIM&R’s 2013 Advancing Ethical Research Conference
Date:11/1/2013

Seattle, WA (PRWEB) November 01, 2013

Quorum Review IRB, the industry leader in central IRB services, announces Regulatory Attorney J. Claire Carbary, JD, CIP, as a presenter at the 2013 PRIM&R Advancing Ethical Research Conference. The conference takes place November 7-9, in Boston, MA.

Ms. Carbary co-presents with J. Andy Bertolatus, Associate Professor of Internal Medicine at The University of Iowa, and Donna A. Messner, Research Director at Center for Medical Technology Policy. The presentation, Electronic Consent: A Discussion of the eConsent Experience, Ethical and Regulatory Considerations and the IRB Review Process, reviews the use of electronic consent using the iPad and computer-based interactive approaches. Presenters examine the regulatory requirements of IRB review and consent documentation and discuss the potential ethical challenges of using electronic technology in streamlining the informed consent process. The presentation takes place Saturday, November 9, at 11:15 AM in room 102.

J. Claire Carbary regularly delivers IRB-focused presentations covering such topics as: social media, HIPAA requirements and safety reporting. Ms. Carbary is a member of the Northwest Association for Biomedical Research and Public Responsibility in Medicine and Research. She received her Juris Doctor from Seattle University in 2007, and was admitted to the Washington State Bar Association (WSBA) in the fall of 2007.

PRIM&R’s annual Advancing Ethical Research Conference is an educational event for professionals working in the field of human subject protection. The conference brings together over 2,500 industry professionals from hospitals, universities, government, and other research institutions in an educational, three-day networking opportunity.

For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

Read the full story at http://www.prweb.com/releases/QuorumReview/Primr2013conference/prweb11275168.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Quorum Review IRB Launches Site Enrollment Service
2. Quorum Review IRB Presents “IRB Review of Registries, Databases and Biobanking” at 2013 AAHRPP Conference
3. Quorum Review IRB to Present “eConsent and the iPad: a Case Study” at Global ACRP Conference
4. Quorum Review IRB Presents on Good Clinical Practice Essentials at MAGI’s 2013 Clinical Research Conference
5. Quorum Review’s CEO Presents on IRB Response to Key Changes in Clinical Research Practice
6. Quorum Review IRB Executive Vice-Chair to Speak at DIA’s 49th Annual Meeting
7. Fitness Revolution Honored as Top Fitness Franchise in Franchise Business Review’s Franchisee Satisfaction Awards
8. Fitness Revolution Receives Franchise Business Review’s Best in Fitness Franchisee Satisfaction Award
9. Kristina, 1904 by Elizabeth Claire Now Available on Kindle
10. Mensa Educational and Research Foundation’s Award for Intellectual Benefit to Society to be presented to ESL author Elizabeth Claire
11. Capture His Heart: Review of Claire Casey And Michael Fiore's Course Released
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: